Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


Adynxx
100 Pine Street, Suite 500
San Francisco, CA 94111
Phone: 415-512-7740
http://www.adynxx.com/index_files/Page402.htm

Adynxx is a clinical-stage pharmaceutical company developing a transformative technology platform addressing pain at its molecular roots - preventing the development of pain following surgery and resolving established chronic pain conditions. Adynxx's unique approach is to transform pain management by approaching pain as a disease rather than a symptom. Adynxx's lead compound, AYX1, is an investigational drug designed to reduce acute post-surgical pain and prevent the transition to persistent or chronic pain with a single administration at the time of surgery.

Key Contact
NameTitleE-Mail
Rick OrrCEOrorr@adynxx.com


Funding Events
DateAmountTypeInvestors
01/11/17$16,000,000Series B Domain Associates
TPG Biotech
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.